Scynexis' Series C - II Round

Scynexis raised a round of funding on March 16, 2006.

Scynexis is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. The company is developing it…

Articles about Scynexis' Series C - II Round: